Assistant Professor
University of Michigan
Dr. Jasmine Luzum’s (formerly Talameh) research focuses on the improvement of pharmacologic outcomes and reduction of racial disparities in patients with cardiovascular disease, especially heart failure. She uses a variety of clinical & translational research approaches, with an emphasis on pharmacogenomics. Her research has been funded by the most prestigious sponsors, published in top journals, and presented at major conferences. Dr. Luzum joined the University of Michigan in July 2016. She received her PharmD summa cum laude from the University of Pittsburgh in 2008 and her PhD in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill Eshelman School of Pharmacy in 2013. She completed a Post-Doctoral Fellowship at the Ohio State University College of Medicine and Center for Pharmacogenomics in 2016. She became a Board-Certified Pharmacotherapy Specialist by the Board of Pharmacy Specialties and an Applied Pharmacologist by the American Board of Clinical Pharmacology in 2015. She became a Fellow of the American Heart Association and the Heart Failure Society of America in 2021.
Disclosure information not submitted.
Tuesday, January 11, 2022
3:45 PM – 4:45 PM ET
.png)